SBFM · NASDAQ
Sunshine Biopharma (SBFM) Stock Price & Fundamentals
Sunshine Biopharma (SBFM) closed at $692.77 on Oct 9, 2026, down 0.96% from the previous close of $699.47.
Share price, past year
1Y +5.17%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $692.77 |
| Sep 30, 2026 | $689.15 |
| Aug 31, 2026 | $681.39 |
| Jul 31, 2026 | $691.73 |
| Jun 30, 2026 | $682.04 |
| May 29, 2026 | $673.98 |
| Apr 30, 2026 | $685.49 |
| Mar 31, 2026 | $665.84 |
| Feb 27, 2026 | $653.86 |
| Jan 30, 2026 | $667.99 |
| Dec 31, 2025 | $721.01 |
| Nov 28, 2025 | $648.66 |
| Oct 31, 2025 | $670.70 |
Key statistics
- Market cap
- $1.65B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $35.35M
- Net income (TTM)
- −$5.83M
- Shares outstanding
- 2.4M
- Dividend yield
- —
- 52-week range
- $646.31 – $729.66
Sunshine Biopharma's market cap is $1.65B, based on a share price of $692.77 and 2.4M shares outstanding as of Jun 30, 2026.
Financials
Sunshine Biopharma reported revenue of $36.31M for fiscal 2025, up 4.11% from fiscal 2024.
Sunshine Biopharma reported a net loss of $5.98M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $36.31M | +4.1% | −$5.98M | −16.5% | — | −$5.51M |
| FY2024ended Dec 31, 2024 | $34.87M | +44.8% | −$5.13M | −14.7% | −$7.32 | −$14.18M |
| FY2023ended Dec 31, 2023 | $24.09M | +454.4% | −$4.51M | −18.7% | −$351.36 | −$8.86M |
| FY2022ended Dec 31, 2022 | $4.35M | +1,802.4% | −$26.74M | −615.4% | −$1.76 | −$5.44M |
| FY2021ended Dec 31, 2021 | $228.43K | +219.9% | −$12.44M | −5,444.4% | −$4.76 | −$1.83M |
| FY2020ended Dec 31, 2020 | $71.41K | +238.1% | −$2.78M | −3,898.7% | — | −$658.49K |
| FY2019ended Dec 31, 2019 | $21.12K | — | −$1.66M | −7,860.9% | — | −$496.66K |
| FY2018ended Dec 31, 2018 | $0.00 | — | −$2.16M | — | — | −$531.66K |
| FY2017ended Dec 31, 2017 | $0.00 | — | −$1.04M | — | — | −$547.24K |
| FY2016ended Dec 31, 2016 | $0.00 | — | −$3.50M | — | — | −$317.62K |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $9.26M | −$1.56M | — |
| Q1 FY2026ended Mar 31, 2026 | $8.09M | −$1.24M | — |
| Q4 FY2025ended Dec 31, 2025 | $8.58M | −$2.14M | — |
| Q3 FY2025ended Sep 30, 2025 | $9.42M | −$883.82K | — |
| Q2 FY2025ended Jun 30, 2025 | $9.41M | −$1.77M | −$0.82 |
| Q1 FY2025ended Mar 31, 2025 | $8.90M | −$1.18M | −$0.44 |
| Q4 FY2024ended Dec 31, 2024 | $9.59M | −$2.16M | — |
| Q3 FY2024ended Sep 30, 2024 | $8.44M | −$1.20M | — |
Company profile
- Name
- Sunshine Biopharma Inc.
- Ticker
- SBFM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 333 Las Olas Way, Cu4 Suite 433, Fort Lauderdale, FL 33301
- Incorporated in
- CO
- Fiscal year ends
- December
- SEC CIK
- 0001402328
Recent SEC filings
- Sep 16, 2026
- Sep 11, 2026
- Aug 28, 2026
- Aug 13, 2026
- Aug 3, 2026
- Jul 20, 2026
- Jul 10, 2026
- May 29, 2026
Frequently asked questions
What is Sunshine Biopharma's stock price?
Sunshine Biopharma (SBFM) closed at $692.77 on Oct 9, 2026, down 0.96% from the previous close of $699.47.
What is Sunshine Biopharma's market cap?
Sunshine Biopharma's market cap is $1.65B, based on a share price of $692.77 and 2.4M shares outstanding as of Jun 30, 2026.
How much revenue does Sunshine Biopharma make?
Sunshine Biopharma reported revenue of $36.31M for fiscal 2025, up 4.11% from fiscal 2024.
Does Sunshine Biopharma pay a dividend?
Sunshine Biopharma's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Sunshine Biopharma Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures